跳至主要内容
临床试验/NCT07360756
NCT07360756尚未招募不适用

Early Prediction of Post-Dural Puncture Headache Using Ultrasound-Measured Optic Nerve Sheath Diameter in Cesarean Section Patients: A Prospective Observational Study

Al-Azhar University0 个研究点目标入组 150 人开始时间: 2026年1月28日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
150

研究概览

简要总结

The Optic Nerve Sheath Diameter (ONSD), measured non-invasively by bedside ultrasound, is a well-established surrogate for intracranial pressure (ICP), as the optic nerve sheath is continuous with the intracranial dura mater and its subarachnoid space is filled with cerebrospinal fluid (CSF). While ONSD is typically used to detect elevated ICP (with a cut-off often > 5.0-5.7 mm for ICP > 20 mmHg), studies investigating PDPH have paradoxically shown a reduction in ONSD post-spinal anesthesia, correlating with the state of intracranial hypotension.

Previous research has demonstrated that a lower ONSD or a significant decrease in ONSD values 24 hours post-puncture is associated with PDPH development. A study determined that an ONSD at 24 hours of less than 0.40 cm was the best predictor for PDPH. Our study aims to specifically investigate the utility of the immediate change in ONSD to offer a bedside, real-time assessment of risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult female patients, aged 18-45 years
  • ASA(American Society of Anesthesiologists) physical status II or III
  • Scheduled for elective cesarean section
  • Undergoing surgery under standardized spinal anesthesia

排除标准

  • Pre-existing headache disorders (e.g., migraine, chronic tension-type headache)
  • Known ophthalmic conditions (e.g., optic neuropathy, glaucoma)
  • Inability to cooperate with ONSD(Optic Nerve Sheath Diameter) ultrasound measurements or follow-up
  • Allergy to local anesthetics
  • Emergency cesarean section
  • Contraindications to spinal anesthesia:
  • Coagulopathy
  • Infection at the puncture site
  • Preexisting hypertension on medication
  • Pre-eclampsia with severe features (suggested for separate study)
  • Known cardiac disease with hemodynamic instability
  • Allergy to study drugs
  • Fetal distress or non-reassuring cardiotocography (CTG)
  • Body Mass Index (BMI) >40 kg/m²
  • Refusal to sign informed consent

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Neveen Abd El Maksoad Kohaf

Lecturer of Clinical Pharmacy

Al-Azhar University

相似试验